Home / Leaderboard / Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
Duane Kuang · Venture Capital · Venture
Qiming Venture Partners is a leading China-based venture capital firm founded in 2006. With offices in Shanghai, Beijing, Suzhou, Hong Kong, and the United States, the firm specializes in early and growth-stage investments in the technology, consumer, and healthcare sectors. It manages approximately $9.5 billion in assets under management across multiple USD and RMB funds. Qiming is recognized for its deep sector expertise and its role as an early backer of iconic companies such as Xiaomi, Meituan, Bilibili, and ByteDance. The firm aims to foster innovation and support entrepreneurs in building world-class businesses by providing strategic resources and a global perspective.
Simulated Performance
| Metric | Value |
|---|---|
| Total return | -8.8% |
| YTD return | +10.0% |
| Sharpe ratio | -3.63 |
| Win rate | 30% |
| AUM | $0.6B |
| Inception | Oct 1, 2025 |
| Updated | Sep 18, 2026 |
Institution Status
| Field | Value |
|---|---|
| AUM | $0.6B |
| Turnover | Low (<15%) |
| Avg holding | 18 Months |
| Inception | Oct 1, 2025 |
| Website | https://www.qimingvc.com |
Current Holdings
Updated on Sep 18, 2026.
| Ticker | Name | Portfolio % | Return |
|---|---|---|---|
| ALMR | Alamar Biosciences, Inc. Common Stock | 49.0% | +41.2% |
| ZLAB | Zai Lab Ltd | 16.7% | -7.3% |
| WRD | WeRide Inc. American Depositary Shares | 16.1% | -46.3% |
| YB | Yuanbao Inc. American Depositary Shares | 8.7% | -33.0% |
| VOR | Vor Biopharma Inc | 7.4% | +44.5% |
| CNTB | Connect Biopharma Holdings Ltd | 2.1% | -19.2% |
| JSPR | Jasper Therapeutics Inc | 0.1% | -73.0% |
| CTKYY | CooTek Cayman Inc | 0.0% | 0.0% |
Recent activity
| Date | Action | Ticker | Weight |
|---|---|---|---|
| Jul 6, 2026 | SELL | JSPR | 0.1% → 0.1% |
| Jul 6, 2026 | BUY | CNTB | 2.0% → 2.1% |
| Jul 6, 2026 | BUY | YB | 8.3% → 8.7% |
| Jul 6, 2026 | SELL | WRD | 26.2% → 16.1% |
| Jul 6, 2026 | SELL | KRRO | 0.7% → 0.0% |
Investment Style Analysis
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited is widely recognized for employing a Venture strategy. As of Sep 18, 2026, the firm oversees approximately $0.6B in assets under management (AUM). The portfolio demonstrates a clear preference for the Medical Devices and Biotechnology sectors, reflecting a high-conviction approach to capital allocation.
Recent Market Moves
During the latest rebalancing period ending Jul 6, Qiming Weichuang Venture Capital Management (Shanghai) Company Limited made a significant move by reducing the position in JSPR. This adjustment aligns with the fund's dynamic approach to risk management and capital deployment in current market conditions.
Investment Philosophy
Qiming Venture Partners strives to be the preferred investor for visionary entrepreneurs by providing strategic support and leveraging a vast industry network. Their investment philosophy centers on identifying and supporting transformative companies at the early and growth stages within the technology and healthcare sectors in China. By emphasizing long-term value creation and maintaining a hands-on approach, the firm helps its portfolio companies navigate critical transitions from startup to market leadership. Qiming focuses on fostering a unique ecosystem where entrepreneurs can access the capital, expertise, and global vision needed to solve complex problems and achieve successful exits.
Disclaimer
The content provided on this page, including the simulated portfolio performance, holdings analysis, and AI-generated insights, is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All data is derived from historical SEC 13F filings and other public disclosures, which have a reporting lag. The "Simulated Performance" is a hypothetical reconstruction based on past disclosures and does not represent the actual returns of the institution. Past performance is not indicative of future results. Tritonix.ai is not affiliated with Qiming Weichuang Venture Capital Management (Shanghai) Company Limited.
Similar Investment Style
Based on Venture.
- Accel Partners — Jim Swartz · 3M +18.1%
- Deer Management Co. LLC — Robert P. Goodman · 3M -8.6%
- New Enterprise Associates, Inc. — Scott Sandell · 3M +6.9%
- Nextech Invest Ltd. — Alfred Scheidegger · 3M +9.7%
Frequently asked questions
How is the simulated portfolio for Qiming Weichuang Venture Capital Management (Shanghai) Company Limited constructed?
This simulation is powered by Tritonix AI using official SEC filings. We focus on the "Best Ideas" by filtering for only the Top 20 largest holdings and rebalancing them to 100%. The simulation tracks performance starting from Oct 1, 2025. Our AI monitors for updates every Monday to capture major shifts. This concentrated approach highlights the manager's true stock-picking skill and mirrors their actual investment returns.
What is Qiming Weichuang Venture Capital Management (Shanghai) Company Limited's largest holding?
As of the latest filing, Qiming Weichuang Venture Capital Management (Shanghai) Company Limited's top position is Alamar Biosciences, Inc. Common Stock (ALMR), representing 49.0% of the portfolio. This reflects a high-conviction bet by the institution.
What is Qiming Weichuang Venture Capital Management (Shanghai) Company Limited's historical performance and risk profile?
Our simulation indicates a total return of -8.8% with a win rate of 30%. Notably, the portfolio maintains a Sharpe Ratio of -3.63, suggesting an standard level of risk-adjusted returns compared to the broader market.
What sectors does Qiming Weichuang Venture Capital Management (Shanghai) Company Limited primarily invest in?
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited has a strong preference for the Medical Devices sector, which makes up 49.0% of their disclosed assets. The portfolio also has exposure to Biotechnology, indicating a specific thematic focus.
Is Qiming Weichuang Venture Capital Management (Shanghai) Company Limited's portfolio concentrated or diversified?
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited runs a highly concentrated portfolio with 8 disclosed positions. The top 3 holdings alone account for 81.8% of the total portfolio weight, suggesting a strategy that favors deep research into a few key names.
How has Qiming Weichuang Venture Capital Management (Shanghai) Company Limited performed in 2026?
Our AI-simulated model portfolio for Qiming Weichuang Venture Capital Management (Shanghai) Company Limited tracks a Year-to-Date (YTD) return of +10.0%. This metric helps investors gauge the institution's effectiveness in the current market environment.
Does Duane Kuang manage Qiming Weichuang Venture Capital Management (Shanghai) Company Limited directly?
Yes, Duane Kuang serves as the key portfolio manager for Qiming Weichuang Venture Capital Management (Shanghai) Company Limited, overseeing the investment strategy and final capital allocation decisions.